Spermine Alleviates Chondrocyte Senescence and Extracellular Matrix Degradation by Suppressing NF-κB Signaling, with Odc1 Acting as a Potential Upstream Regulator
- 1Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuchang District, Wuhan 430060, China
Abstract
Osteoarthritis (OA) is a prevalent degenerative joint disease with no disease-modifying therapy currently available. Spermine (SPM), a natural polyamine, shows therapeutic potential, but its role and mechanism in OA remain unclear. In this study, SPM expression was examined in OA cartilage, and the effects of exogenous SPM on chondrocyte senescence and extracellular matrix degradation were assessed in vitro and in a rat OA model. Bioinformatics analysis and Odc1 knockdown experiments were performed to identify the upstream regulator of SPM. The results showed that SPM was significantly downregulated in TBHP-stimulated chondrocytes. Exogenous SPM supplementation alleviated chondrocyte senescence, inhibited matrix degradation, and attenuated cartilage degeneration in vivo. Mechanistically, SPM inhibited NF-κB signaling, and Odc1 was identified as a key upstream regulator of SPM. In conclusion, SPM alleviates chondrocyte senescence and matrix degradation in vitro and attenuates OA progression in vivo. These effects are partially achieved by suppressing NF-κB signaling and upregulating Odc1, indicating that SPM is a promising therapeutic candidate for OA.
Related
- The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis
- M2 Macrophage‐Derived Small Extracellular Vesicle miR‐106a‐Loaded QCG Hydrogel Targets the RNF128‐LXR Pathway to Reprogram Chondrocyte Cholesterol Metabolism for Osteoarthritis Therapy
- Bergapten Alleviates Periodontitis by Suppressing NLRP3 Inflammasome Activation via Mitophagy-Induced Disruption of NEK7-NLRP3 Interaction.
- Senescent Cell‐Derived Extracellular Vesicles in Therapy‐Induced Senescence: Immune Remodelling and Emerging Links to Mitochondrial Stress in Cancer
- The plant longevity gene AHL15 delays leaf senescence by repressing ORESARA1 and cytokinin degradation.
BibTeX
@article{shi2026spermine,
title = {{Spermine Alleviates Chondrocyte Senescence and Extracellular Matrix Degradation by Suppressing NF-κB Signaling, with Odc1 Acting as a Potential Upstream Regulator}},
author = {Rui Shi and Rongling Feng and Junming Zhu and Panghu Zhou},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = nov,
doi = {10.3390/ijms27219859},
url = {https://www.mdpi.com/1422-0067/27/21/9859},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Spermine Alleviates Chondrocyte Senescence and Extracellular Matrix Degradation by Suppressing NF-κB Signaling, with Odc1 Acting as a Potential Upstream Regulator
AU - Rui Shi
AU - Rongling Feng
AU - Junming Zhu
AU - Panghu Zhou
PY - 2026
DA - 2026/11/03
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27219859
UR - https://www.mdpi.com/1422-0067/27/21/9859
AB - Osteoarthritis (OA) is a prevalent degenerative joint disease with no disease-modifying therapy currently available. Spermine (SPM), a natural polyamine, shows therapeutic potential, but its role and mechanism in OA remain unclear. In this study, SPM expression was examined in OA cartilage, and the effects of exogenous SPM on chondrocyte senescence and extracellular matrix degradation were assessed in vitro and in a rat OA model. Bioinformatics analysis and Odc1 knockdown experiments were performed to identify the upstream regulator of SPM. The results showed that SPM was significantly downregulated in TBHP-stimulated chondrocytes. Exogenous SPM supplementation alleviated chondrocyte senescence, inhibited matrix degradation, and attenuated cartilage degeneration in vivo. Mechanistically, SPM inhibited NF-κB signaling, and Odc1 was identified as a key upstream regulator of SPM. In conclusion, SPM alleviates chondrocyte senescence and matrix degradation in vitro and attenuates OA progression in vivo. These effects are partially achieved by suppressing NF-κB signaling and upregulating Odc1, indicating that SPM is a promising therapeutic candidate for OA.
SN - 1422-0067
ER -